Psoralidin is primarily studied for its potential therapeutic applications in various medical fields. It has shown significant promise in cancer research, particularly for breast and prostate cancers, due to its ability to induce apoptosis and inhibit the growth of cancer cells. Additionally, it exhibits anti-inflammatory properties by inhibiting the production of inflammatory mediators such as cytokines and COX-2 enzyme, making it a candidate for treating inflammatory diseases. Psoralidin is also being explored for its neuroprotective effects, which could be beneficial in managing neurodegenerative disorders. Furthermore, its antioxidant properties help protect cells from oxidative damage, contributing to potential uses in anti-aging and preventing chronic diseases. Recent studies indicate it promotes bone health by stimulating osteoblast formation and preventing bone resorption. Research continues to uncover its full range of applications in pharmacology and medicine, positioning it as a promising compound for developing new drugs and health products.